Hiring in life sciences? Share your open positions with our professional community. Read more Close

Advertisement

Ovarian Sex Cord Stromal Tumors in Children and Adolescents-The European Standard Clinical Practice Recommendations.

Created on 27 Jul 2026

Authors

Dominik T Schneider, Kris-Ann Schultz, Nora Schnitzler, Michael Abele, Tal Ben-Ami, Ewa Bien, Gianni Bisogno, Ines B Brecht, Maja Cesen, Andrea Ferrari, Michaela Kuhlen, Malgorzata A Krawczyk, Ricardo Lopez-Almaraz, Yves Reguerre, Calogero Virgone, Daniel Orbach

Published in

Pediatric blood & cancer. Pages e70571. Jul 27, 2026. Epub Jul 27, 2026.

Abstract

As part of the European Cooperative Study Group for Paediatric Rare Tumours initiative, we developed standard clinical practice guidelines for ovarian sex cord stromal tumors, based on comprehensive national and international cohort analyses, literature review, and a final expert consensus conference. Complete tumor resection is the cornerstone of treatment, with meticulous attention to preventing tumor spillage. Risk stratification of adjuvant chemotherapy decisions incorporates tumor stage and critical parameters, including histological differentiation and mitotic rate. Optimal patient management requires treatment within cooperative networks providing centralized histopathological review and comprehensive genetic testing, multidisciplinary tumor board evaluation, and prospective registry enrollment to advance knowledge for these exceptionally rare malignancies.

PMID:
42504512
Bibliographic data and abstract were imported from PubMed on 27 Jul 2026.

Read full publication at:
Please sign in to see all details.

Advertisement

Stats

  • Community rating n/a 0 votes
  • Reviewers' rating n/a 0 votes
  • Your rating

1-terrible, 9-excellent. How would you rate this publication? Sign in in to submit your rating.

  • Recommendations n/a n/a positive of 0 vote(s)
  • Views 6
  • Comments 0

Recommended by

  • No recommendations yet.

Post a comment

You need to be signed in to post comments. You can sign in here.

Comments

There are no comments yet.

Advertisement